Log in to save to my catalogue

Multifactorial expression of IL-6 with update on COVID-19 and the therapeutic strategies of its bloc...

Multifactorial expression of IL-6 with update on COVID-19 and the therapeutic strategies of its bloc...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7851683

Multifactorial expression of IL-6 with update on COVID-19 and the therapeutic strategies of its blockade (Review)

About this item

Full title

Multifactorial expression of IL-6 with update on COVID-19 and the therapeutic strategies of its blockade (Review)

Publisher

Greece: Spandidos Publications

Journal title

Experimental and therapeutic medicine, 2021-03, Vol.21 (3), p.263-263, Article 263

Language

English

Formats

Publication information

Publisher

Greece: Spandidos Publications

More information

Scope and Contents

Contents

Interleukin 6 (IL-6), a cytokine produced by various cells of the human body (macrophages, lymphocytes, astrocytes, ischemic myocytes, endothelial cells) has both pro-inflammatory and anti-inflammatory properties, being a key component in regulating various physiologic and pathological processes. The structure of this molecule and the receptor syst...

Alternative Titles

Full title

Multifactorial expression of IL-6 with update on COVID-19 and the therapeutic strategies of its blockade (Review)

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7851683

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7851683

Other Identifiers

ISSN

1792-0981

E-ISSN

1792-1015

DOI

10.3892/etm.2021.9693

How to access this item